Stay updated with breaking news from Oakrum Pharma. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
-- Expect Q1 2024 product launch ---- Nitisinone market estimated to be more than $50 million annually ---- Eton will offer Eton Cares support program to all patients -- DEER PARK, Ill., Oct. 04,...
Toxoplasmosis is an infection caused by common parasite, which is found in cat feces and in contaminated food. This parasite is known as Toxoplasma gondii. The symptoms of toxoplasmosis disease include body aches and pain, headache, fatigue, fever, and swollen lymph nodes. In addition, people with weakened immune sy...
Second Quarter 2022 Results:-- Net revenues of $73.9 million, net loss available to common shareholders of $(15.3) million and diluted GAAP loss per share of $(0.94) –-- Lead Rare Disease asset, Purified Cortrophin® Gel (Repository Corticotrophin Injection USP) 80 U/ml (Cortrophin) net sales of $10.2 million ---- Ad...
08.08.2022 - ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) (ANI or the Company) today announced business highlights and financial results for the three and six months ended June 30, 2022. “Second quarter net revenues of $73.9 million represent a new quarterly record ...
Global Rare Disease Treatment Market is Expanding at a CAGR of 15.76% over the Forecast Period (2022 – 2030)